Investors looking to find promising growth chances often meet the task of matching a company's core financial health with good market timing. One way to handle this is by using strict fundamental and technical study together. The method looks for companies showing solid and speeding financial growth, a sign of a real growth stock, while also showing technical chart shapes that point to a possible move out from a time of sideways trading. This two-part method tries to pick stocks where strong business force might be close to being seen and shown in the share price.
HEALTHEQUITY INC (NASDAQ:HQY) works in the healthcare technology field, giving services for health savings accounts (HSAs) and other consumer-directed benefits. As a helper for tax-advantaged healthcare spending, the company sits in a big and necessary market, a main qualitative point for lasting growth. The continuing move toward consumer-driven healthcare plans points to a long-term path for increase, if the company performs well.
Fundamental Growth Review
A close look at the company's fundamentals shows why it meets the first growth stock filter. Based on the full fundamental analysis report, HealthEquity gets a good Growth Rating of 7 out of 10. This score comes from notable past results and good future outlooks.
- Good Past Growth: The company has shown major increase in its main financial measures.
- Revenue has increased by 12.20% over the last year and at a normal yearly rate of 17.66% over recent years.
- Earnings Per Share (EPS) increase is more notable, rising by 22.15% in the last year.
- Speeding Profit Gain: Maybe more key, the EPS increase rate is getting faster. The study shows that future expected yearly EPS growth of 19.43% is higher than the past normal, meaning the company's profit engine is getting stronger.
- Base of Quality: For growth to last, it must rest on a steady base. HealthEquity backs its growth with good Profitability and Financial Health ratings (both 7/10). Main strong points include:
- Very good profit and operating margins that place near the best in its industry.
- A very sound balance sheet with a high current ratio and a workable debt-to-equity ratio, showing good cash flow and low default danger.
This pairing is key for the method: strong, speeding earnings growth supports the "growth stock" idea, while good profitability and financial health lower the danger that this growth is weak or fed by too much debt.
Technical Picture for a Possible Move
While the fundamentals show a healthy, growing company, the technical study judges the market's present feeling and possible price path. HealthEquity's technical analysis report gives a detailed picture. The total technical rating is low, pulled down by a long-term negative trend and poor relative results over the past year. However, the report points out a notable Setup Rating of 7 out of 10, finding a specific chance inside the wider down trend.
The setup means that after a big fall from its 52-week highs, the stock has started a phase of sideways trading. Prices have been moving in a band between about $72.76 and $84.11 over the past month, with the present price in the middle. This time of lower change and flat movement can often come before a new directional shift.
- Main Resistance and Support: The technical shape shows very little nearby resistance above the present price, meaning a move up could meet fewer blocks at first. Below, a set support area exists near $77.90, which could work as a logical place for a stop-loss order if the expected move does not happen.
- Market Setting: It is important that this possible setup is happening while the wider S&P 500 shows a positive short-term trend. A stock moving out from sideways trading into a rising market can gain from helpful winds.
This technical shape is exactly what the screening method wants: a fundamentally sound company whose stock price has been disliked but is now showing signs of settling and could be getting ready for a turn, giving a good risk/reward entry point.
Valuation Points
Even the top growth story must be bought at a sensible price. HealthEquity's valuation numbers give a mixed but generally acceptable picture. With a P/E ratio of 20.90, the stock trades below both its industry normal and the wider S&P 500. More forward-looking numbers, like the Price/Forward Earnings ratio of 16.97, also mean a valuation that is sensible compared to peers. When this valuation is viewed next to the company's high expected earnings growth rate, the stock seems fairly priced for its growth picture, staying away from the extreme high price that can hurt many growth stories.
Summary
HealthEquity shows a case that fits a joined growth and technical move method. Fundamentally, it shows the needed signs of speeding earnings growth, high profitability, and financial strength. Technically, after a long down trend, the stock chart shows a shape of sideways trading with a clear support level and little above resistance, meaning a possible turning point. For investors using this approach, HQY stands as an example of a company where strong business results might be set to meet a positive change in market price movement.
Find Other Possible Choices This study of HealthEquity came from a specific screen for "Strong Growth Stocks with good Technical Setup Ratings." If this method fits your investment style, you can view and change this screen to find other similar chances.
Disclaimer: This article is for information and learning only and does not form a suggestion to buy or sell any security. The study is based on data and reports given by other parties. Investing includes risk, including the possible loss of original funds. You should do your own study and talk with a qualified financial advisor before making any investment choices.
